VALNEVA Declaration of shares and voting rights: June 30, 2025 VALNEVA Declaration of shares and voting rights June 30, 2025__________________________________________________________________________________________ Company name: VALNEVARegistered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France)Regulated market of Euronext Paris - Compartment B Declaration date: July 3, 2025 Number of shares composing the share capital of ValnevaTotal number of voting rights including suspended voting rights*Description of the change Date on which this change was recognizedTotal number of voti...
VALNEVA Déclaration d’actions et de droits de vote : 30 juin 2025 VALNEVA Déclaration d’actions et de droits de vote 30 juin 2025__________________________________________________________________________________________ Dénomination sociale : VALNEVAAdresse du siège social : 6 rue Alain Bombard, 44800 Saint-HerblainMarché réglementé Euronext Paris - Compartiment B Date de la déclaration : 3 juillet 2025 Nombre d’actions composant le capital de ValnevaNombre total de droits de vote incluant les droits de vote suspendus*Origine de la variationDate à laquelle cette variation a été consta...
The sector newsflow is improving but the valuation is at a low (P/B = 1x, EV/EBITDA ratio identical to that of Siltronic). We remain positive on the stock (target price raised from € 54 to € 58 on a reduction in the governance discount). In the short term, the size of inventories at customers justifies a further reduction in our earnings estimates.
Alors que le newsflow sectoriel s’améliore, la valorisation est au plus bas (P/B = 1x, VE/EBITDA identique à Siltronic…). Nous restons positifs sur la valeur (objectif relevé de 54 € à 58 € avec la réduction de la décote de gouvernance). A court terme, l’ampleur des stocks chez les clients justifie de baisser de nouveau nos prévisions de résultats.
Combined General Meeting of July 22, 2025 Conditions for Obtaining the Preparatory Documents COMBINED GENERAL MEETINGOF JULY 22, 2025 CONDITIONS FOR OBTAINING THE PREPARATORY DOCUMENTS Bernin (Grenoble), France, on July 1, 2025 - Soitec (Euronext Paris) reminds that the Company’s shareholders are invited to attend the Annual General Meeting to be held on Tuesday July 22, 2025 at 9:30 a.m. (Paris time), in the Auditorium of the VERSO conference Center located at 52 rue de la Victoire, 75009 Paris, France. The preliminary meeting notice serving as convening notice as provided for ...
ASSEMBLEE GENERALE MIXTE DU 22 JUILLET 2025 MODALITÉS DE MISE À DISPOSITION DES DOCUMENTS PRÉPARATOIRES ASSEMBLEE GENERALE MIXTEDU 22 JUILLET 2025 MODALITÉS DE MISE À DISPOSITION DES DOCUMENTS PRÉPARATOIRES Bernin (Grenoble), France, le 1er juillet 2025 - Soitec (Euronext Paris) rappelle que les actionnaires de la Société sont invités à participer à l’Assemblée Générale Mixte qui se tiendra le mardi 22 juillet 2025 à 9 heures 30 (heure de Paris), à l’Auditorium du Centre de conférences VERSO situé 52 rue de la Victoire, 75009 Paris. L’avis de réunion, valant avis de convocati...
A director at Valneva SE bought 10,000 shares at 2.431EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...
Valneva annonce un accord exclusif avec CSL Seqirus pour le marketing et la distribution de ses vaccins en Allemagne Saint-Herblain, France, le 26 juin 2025 – (Nasdaq : VALN ; Euronext Paris : VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui un accord exclusif avec CSL Seqirus, l'une des plus grandes entreprises de vaccins antigrippaux au monde, pour le marketing et la distribution des trois vaccins commerciaux de Valneva en Allemagne. Selon les termes de l'accord, CSL Seqirus commencera à commercialiser le vaccin unidose contre le chikungunya, IXCHIQ®, de Valneva à part...
Valneva Announces Exclusive Vaccine Marketing and Distribution Agreement for Germany with CSL Seqirus Saint-Herblain, France, June 26, 2025 – , (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced an exclusive agreement with CSL Seqirus, one of the world’s largest influenza vaccine companies, for the marketing and distribution of Valneva’s three proprietary vaccines in Germany. Under the agreed terms, CSL Seqirus will start commercializing Valneva’s single-dose chikungunya vaccine IXCHIQ® from July 2025, and Valneva’s Japanese Encephalitis vaccine IXIARO® and ...
Valneva Announces Successful Outcome of its Annual General Meeting, Confirms FY 2025 guidance Saint-Herblain (France), June 25, 2025 – (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that all the resolutions recommended by the Board of Directors were approved by the shareholders at its Annual General Meeting held today in Lyon, France. Among the adopted resolutions were the approval of the 2024 financial statements, delegations for the Board of Directors to increase Valneva’s share capital and/or issue financial instruments, the appointment of Dr. Gerd Z...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.